Superficial Thrombophlebitis
📧 Sign up to get email alerts when something new happens for Superficial Thrombophlebitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients [NA]
A completed study comparing the DOACT algorithm to AI-based decision models for guiding oral anticoagulant therapy in vascular conditions.
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis [Phase 4]
Phase 4 trial evaluating the efficacy of low molecular weight heparin for superficial thrombophlebitis has been completed.
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: ARIXTRA® Adherence in SVT Patients.
A clinical trial update reports on fondaparinux (Arixtra) adherence in patients with superficial thrombophlebitis (SVT). The study status is…
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Management of Superficial Thrombophlebitis [Phase 4]
Phase 4 clinical trial update on management of superficial thrombophlebitis (upper and lower extremity forms) with completed status and resu…
-
CLINICAL_TRIALS trial_result · 2010-08-02Clinical Trial Update: Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) [Phase 3]
A Phase 3 study evaluated subcutaneous fondaparinux 2.5 mg daily for the treatment of superficial thrombophlebitis; the trial has completed …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-01-13Clinical Trial Update: POST (Prospective Observational Superfial Thrombophlebitis)
A prospective observational study on superficial thrombophlebitis has completed.